DH DEFINITIVE HEALTHCARE CORP

Definitive Healthcare greatly expands all-payor medical and prescription claims coverage

Definitive Healthcare greatly expands all-payor medical and prescription claims coverage

60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuum

FRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: ), an industry leader in healthcare commercial intelligence, today announced expanded coverage of its prescription and all-payor medical claims data in the . The company’s Atlas Prescription Claims coverage increased by more than 60%, and its Atlas All-Payor Claims coverage also increased significantly, including nearly 20% increases in key areas such as rare disease, oncology, and chronic conditions.

With expanded claims data, any organization partnering with healthcare providers to improve patient care and outcomes can view an in-depth and holistic look at the patient journey across the healthcare continuum to better understand market trends, inform product development, and optimize go-to-market strategy.

“The Atlas Dataset is the foundation of our healthcare commercial intelligence, and the expanded coverage of both prescription and all-payor claims will help our clients accelerate their path to commercial success,” said Robert Musslewhite, CEO of Definitive Healthcare. “We’re excited to increase both the quantity and quality of our Atlas claims datasets to paint a more comprehensive picture of a patient’s journey as part of our ongoing strategy to invest in powerful, real-world data. With the Atlas Dataset, our life sciences customers can more easily and quickly get their drugs and devices to the patients that need them.”

Along with the increased claims volume, Definitive Healthcare refined its methodologies to master payor and patient data to drive increased precision and implemented additional layers of cleansing techniques to enable more detailed and granular reporting, longitudinal and referral analysis, and increased accuracy for patient cohort creation. As a result of the improved underlying methodology and adding new sources, Definitive Healthcare nearly doubled the size of its patient overlap across datasets.

When coupled with the broader , including best-in-class affiliations and reference data, the new claims assets provide Definitive Healthcare customers with industry-leading intelligence on provider behavior, providers’ affiliation and referral patterns, patient care, and the activities taking place within a facility.

To learn more about the Atlas All-Payor Claims and Atlas Prescription Claims, visit:

About Definitive Healthcare 

At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at . 

Media Contacts:

Danielle Johns

Highwire PR:

 

Investor Relations Contact:

Brian Denyeau

ICR for Definitive Healthcare





EN
02/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEFINITIVE HEALTHCARE CORP

 PRESS RELEASE

Definitive Healthcare Reports Financial Results for Second Quarter Fis...

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2025 Second Quarter Revenue Exceeded Guidance FRAMINGHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2025.  Second Quarter 2025 Financial Highlights: Revenue was $60.8 million, a decrease of 5% from $63.7 million in Q2 2024. Net Loss was $(9.3) million, or (15)% of revenue, compared to $(306.2) million in...

 PRESS RELEASE

Definitive Healthcare Announces Timing of Its Second Quarter 2025 Fina...

Definitive Healthcare Announces Timing of Its Second Quarter 2025 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the ev...

 PRESS RELEASE

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeannine Lombardi, Definitive Healthcare’s new Chief Human Resource Officer, an inducement award consisting of 421...

 PRESS RELEASE

Definitive Healthcare Corp. reports inducement grants under Nasdaq Lis...

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted an inducement award. The Committee granted Tina Hannagan, Definitive Healthcare’s Chief Commercial Officer, an inducement award consisting of 830,565 t...

 PRESS RELEASE

Definitive Healthcare Reports Financial Results for First Quarter Fisc...

Definitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2025 First Quarter Revenue Exceeded Guidance FRAMINGHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended March 31, 2025.  First Quarter 2025 Financial Highlights: Revenue was $59.2 million, a decrease of 7% from $63.5 million in Q1 2024. Net Loss, inclusive of goodwill impairment charges of $176.5 million, was $(155.1) m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch